{"id":5253,"date":"2014-11-22T15:14:06","date_gmt":"2014-11-22T15:14:06","guid":{"rendered":"\/?p=5253"},"modified":"2014-11-22T15:14:09","modified_gmt":"2014-11-22T15:14:09","slug":"american-green-inc-otcmktserbb-turns-limited-information","status":"publish","type":"post","link":"\/articles\/american-green-inc-otcmktserbb-turns-limited-information\/","title":{"rendered":"American Green, Inc. (OTCMKTS:ERBB) Turns Limited Information"},"content":{"rendered":"\n

American Green, Inc. (OTCMKTS:ERBB<\/a>) slid 4.35% down yesterday, as its tag on the OTC Markets was changed to “OTC Pink Limited Information<\/em>”. <\/p>\n

Many investors were excited about the company’s upcoming financial report, that was already delayed once through an official filing. Even now, ERBB<\/a><\/strong> enthusiasts and opportunistic pot-stock traders alike are holding their breath in anticipation of said filing. The only question question is – why?<\/p>\n

As far as due diligence shows, ERBB<\/a><\/strong> doesn’t really have revenues, so it’s not like its financials can be all that impressive. With the promised roll-out being delayed on at least three occasions already, there can’t be all that much money going the company’s way, can there?<\/p>\n

Idle as ERBB<\/a><\/strong> is, the only thing such a report could be good for is discerning how much money the company has spent in the last quarter in order to fail to roll-out a product, how much toxic funding has it burdened investor with this time around, and how much dilution could investors be looking forward to in the near future.<\/p>\n

This being the case, it should be obvious why ERBB<\/a><\/strong> has been lax with its reporting. Currently, there is no real way to know whether the company is just negligent or is buying time, but in either case – the present state of developments does not really bode well for ERBB<\/a><\/strong>.<\/p>\n